K. Blyth (Glasgow (Glasgow), United Kingdom), A. Charpidou (Athens, Greece), I. Rousalova (Praha, Czech Republic), D. Kauffmann-guerrero (Munich, Germany)
Role of chemokines in resectable non-small cell lung cancer (NSCLC)
M. Drösslerová (Prague, Czech Republic), M. Sterclová (Prague, Czech Republic), A. Tašková (Prague, Czech Republic), V. Hytych (Prague, Czech Republic), P. Horaždovský (Prague, Czech Republic), E. Richterová (Prague, Czech Republic), M. Smetáková (Prague, Czech Republic), M. Vašáková (Prague, Czech Republic)
|  |
Maximum Standard Unit Value (SUVmax) is an indicator for overall survival in lung cancer
D. Groves (stevenage, United Kingdom), N. Noor Al-Nuaimi (London, United Kingdom), B. Ganeshan (London, United Kingdom), T. Win (stevenage, United Kingdom)
|  |
Analysis of survival and characteristics of patients with non-small cell lung carcinoma (NSCLC) stage IV depending on molecular markers
J. Andia Iturrate (BILBAO, Spain), P. Jimenez (BILBAO, Spain), L. Ansola (BILBAO, Spain), M. Saiz (BILBAO, Spain), L. Garcia (BILBAO, Spain), B. Gonzalez (BILBAO, Spain), E. Garay (BILBAO, Spain), P. Ansola (BILBAO, Spain)
| |
Prognostic factors in lung cancer:is age an independent predictive factor?
T. Diaz De Teran Lopez (Santander, Spain), L. Sanchez Moreno (Santander, Spain), K. Lee (Auckland, New Zealand), C. Magadan Alvarez (Santander, Spain), V. Mora Cuesta (Santander, Spain), S. Naranjo Gozalo (Santander, Spain), B. Abascal Bolado (Santander, Spain), V. Maderuelo García (Palencia, Spain), P. Lozano Cuesta (Burgos, Spain), D. Iturbe Fernández (Santander, Spain), D. Ferrer Pargada (Santander, Spain), A. Martínez Meñaca (Santander, Spain), C. Amado Diago (Santander, Spain), J. Ruiz Cubillán (Santander, Spain), D. Andia Torrico (Santander, Spain), J. Cifrián Martinez (Santander, Spain)
| |
Clinical impact of steps-count during hospitalization after surgery in lung cancer patients
J. Rodriguez Torres (Granada, Spain), L. Cahalin (Miami, United States of America), M. Granados-Santiago (Granada, Spain), R. Romero-Fernández (Granada, Spain), I. Torres-Sánchez (Granada, Spain), M. Valenza (Granada, Spain)
| |
Value of positron emission tomography parameters for the prognosis of small-cell lung carcinoma
Ö. Özdemir (Izmir, Turkey), Ö. Batum (Izmir, Turkey), S. Ermin (Izmir, Turkey), N. Aksel (Izmir, Turkey), B. Kömürcüoglu (Izmir, Turkey), A. Mertoglu (Izmir, Turkey), S. Deniz (Izmir, Turkey), G. Balci (Izmir, Turkey), H. Koparal (Izmir, Turkey), E. Özbilek (Izmir, Turkey), U. Yilmaz (Izmir, Turkey)
| |
Prognostic value of symptoms at lung cancer diagnosis: a two-year observational study
D. Polanco Alonso (Lleida, Spain), A. Mas (Lleida, Spain), S. Bertran (Lleida, Spain), G. Fierro (Lleida, Spain), A. Seminario (Tarragona, Spain), S. Gomez (Lleida, Spain), F. Barbe (Lleida, Spain)
| |
LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years
S. Raimundo (Vila Real, Portugal), A. Loureiro (Vila Real, Portugal), F. Vieira (Trofa, Portugal), A. Fernandes (Vila Real, Portugal)
| |
Characteristics of Patients with Large-Cell Neuroendocrine Carcinoma of the Lung
A. Cirak (Izmir, Turkey), K. Ceylan (Izmir, Turkey), Y. Varol (Izmir, Turkey), G. Karadeniz (Izmir, Turkey), Z. Aydogdu (Izmir, Turkey), A. Acar (Izmir, Turkey), G. Balci (Izmir, Turkey), B. Komurcuoglu (Izmir, Turkey), A. Mertoglu (Izmir, Turkey), Z. Ondes (Izmir, Turkey), S. Tekgul (Izmir, Turkey), G. Vayisoglu (Izmir, Turkey), E. Yalniz (Izmir, Turkey)
| |
Incidence and outcome of lung cancer in patients with chronic respiratory failure
T. Lambert (Rouen, France), K. El-Husseini (Rouen, France), E. Dantoing (Rouen, France), J. Dupuis (Isneauville, France), F. Guisier (Rouen, France), M. Salaun (Rouen, France), S. Bota (Rouen, France), M. Roger (Rouen, France), A. Cuvelier (Rouen, France), L. Thiberville (Rouen, France), M. Patout (Rouen, France)
| |
Evaluation of gene mutation status and metastasis in lung adenocarcinoma: a multicentric prospective study in Turkey
S. Yilmaz (Eskisehir, Turkey), S. Metintas (Eskisehir, Turkey), M. Karadag (Bursa, Turkey), N. Yilmaz Demirci (Ankara, Turkey), O. Aydin Guclu (Bursa, Turkey), P. Akin Kabalak (Ankara, Turkey), U. Yilmaz (Ankara, Turkey), G. Ak (Eskisehir, Turkey), D. Kizilgöz (Ankara, Turkey), A. Ozturk (Istanbul, Turkey), U. Yilmaz (Izmir, Turkey), O. Batum (Izmir, Turkey), M. Kavas (Istanbul, Turkey), I. Serifoglu (Ankara, Turkey), M. Unsal (Samsun, Turkey), B. E. Komurcuoglu (Izmir, Turkey), T. Inal Cengiz (Ankara, Turkey), G. Ulubay (Ankara, Turkey), T. S. Ozdemirel (Ankara, Turkey), B. A.Ozyurek (Ankara, Turkey), S. Kavurgaci (Ankara, Turkey), D. Alizoroglu (Izmir, Turkey), P. Celik (Izmir, Turkey), Y. Erdogan (Ankara, Turkey), A. Zamani (Konya, Turkey), E. In (Elazig, Turkey), A. Aksoy (Elazig, Turkey), S. Altin (Istanbul, Turkey), G. Gunluoglu (Istanbul, Turkey), M. Metintas (Eskisehir, Turkey)
| |
Human cytomegalovirus infection effects on lung cancer prognosis after surgical resection
J. Cortón Ruiz (Bialystok, Poland), L. Lücke (Bialystok, Poland), L. Minarowski (Bialystok, Poland), O. Kowalczuk (Bialystok, Poland)
| |
Molecular biology of advanced NSCLC and survival: seeking the best therapy
M. Martins Baptista (Covilhã, Portugal), N. Martins (Porto, Portugal), J. Barata (Covilhã, Portugal), R. Silva (Covilhã, Portugal), S. Martins (Covilhã, Portugal), A. Craveiro (Covilhã, Portugal), M. Valente (Covilhã, Portugal), E. Magalhães (Covilhã, Portugal), I. Vicente (Covilhã, Portugal), M. Valente (Covilhã, Portugal)
| |
Correlation in expression change between transposons and adjacent genes reveal importance of genomic location in lung cancer.
M. Arroyo Varela (Málaga, Spain), E. Salcedo Lobera (Málaga, Spain), R. Bautista Moreno (Málaga, Spain), R. Larrosa Jiménez (Málaga, Spain), J. De La Cruz Ríos (Málaga, Spain), G. Claros Díaz (Málaga, Spain)
| |
Analyses of prognostic factors in patients undergoing surgery for lung cancer.
Y. Noda (Tokyo, Japan), H. Matsudaira (Tokyo, Japan), H. Ogawa (Tokyo, Japan), D. Kato (Tokyo, Japan), S. Mori (Tokyo, Japan), T. Nakada (Tokyo, Japan), H. Asano (Tokyo, Japan), T. Ohtsuka (Tokyo, Japan)
| |
Classic and Novel Adipokines as diagnostic biomarkers in NSCLC
G. Sotiropoulos (Athens, Greece), G. Christodoulatos (Athens, Greece), I. Karampela (Athens, Greece), G. Antonakos (Athens, Greece), I. Marinou (Athens, Greece), M. Kotopouli (Athens, Greece), E. Vogiatzakis (Athens, Greece), A. Lekka (Athens, Greece), A. Papavassiliou (Athens, Greece), M. Dalamaga (Athens, Greece)
| |
Chemerin and PAI-1 activity as diagnostic biomarkers in resectable NSCLC:comparison to classic tumour markers
G. Sotiropoulos (Athens, Greece), M. Kotopouli (Athens, Greece), I. Karampela (Athens, Greece), G. Christodoulatos (Athens, Greece), G. Antonakos (Athens, Greece), I. Marinou (Athens, Greece), E. Vogiatzakis (Athens, Greece), A. Lekka (Athens, Greece), A. Papavassiliou (Athens, Greece), M. Dalamaga (Athens, Greece)
| |
The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients.
S. DAI (Chengdu, China), L. Yang (Chengdu, China), L. Li (Chengdu, China), W. Li (Chengdu, China)
| |
Pulmonary carcinoid tumor: a single institution experience
K. Krpina (Zagreb , Croatia), S. Kukulj (Zagreb , Croatia), B. Budimir (Zagreb , Croatia), M. Jakopovic (Zagreb , Croatia), M. Samaržija (Zagreb , Croatia), L. Batelja (Zagreb , Croatia), Ž. Djakovic (Zagreb , Croatia)
| |
Expression of PARP in lung cancer: Patients with COPD and mice
J. Tang (BARCELONA, Spain), J. Yelamos (BARCELONA, Spain), C. Ampurdanes (BARCELONA, Spain), A. Salazar-Degracia (BARCELONA, Spain), X. Wang (BARCELONA, Spain), L. Pijuan (BARCELONA, Spain), V. Curull (BARCELONA, Spain), E. Barreiro Portela (BARCELONA, Spain)
| |